Artwork

Content provided by The Radcliffe Cardiology Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Radcliffe Cardiology Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Player FM - Podcast App
Go offline with the Player FM app!

Ep 4: The EXCEL Trial: The Interventionalists’ Perspective

12:40
 
Share
 

Manage episode 318823677 series 2990303
Content provided by The Radcliffe Cardiology Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Radcliffe Cardiology Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Did you know that left main stem disease is identified in 5% of diagnostic angiography cases? The EXCEL trial was a randomised clinical trial published in 2019 which studied left main stem disease of low or intermediate complexity. The trial came under controversy due to its definition of MI, leading to a loss in patient and public trust, and a deterioration in the relationship between the cardiothoracic and PCI communities. In this month's featured author episode of the ECR Podcast, interventional fellow Dr George Hunter (Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK) discusses the EXCEL trial from his perspective as a member of the PCI community, based on a recent review paper: https://www.ecrjournal.com/articles/excel-trial-interventionalists-perspective?_ga=2.187238699.2063070761.1642409370-1520007507.1640163023 from the ECR Journal. In this podcast, Dr Hunter discusses the controversy surrounding the trial and the importance of studying left main stem disease in cardiology today. If you would like to learn more about the EXCEL Trial, view our special collection here: https://www.ecrjournal.com/special-collections/445/recent Episodes are released on the last Friday of each month. If you have any questions, please email managingeditor@ecrjournal.com.
  continue reading

36 episodes

Artwork
iconShare
 
Manage episode 318823677 series 2990303
Content provided by The Radcliffe Cardiology Podcast. All podcast content including episodes, graphics, and podcast descriptions are uploaded and provided directly by The Radcliffe Cardiology Podcast or their podcast platform partner. If you believe someone is using your copyrighted work without your permission, you can follow the process outlined here https://player.fm/legal.
Did you know that left main stem disease is identified in 5% of diagnostic angiography cases? The EXCEL trial was a randomised clinical trial published in 2019 which studied left main stem disease of low or intermediate complexity. The trial came under controversy due to its definition of MI, leading to a loss in patient and public trust, and a deterioration in the relationship between the cardiothoracic and PCI communities. In this month's featured author episode of the ECR Podcast, interventional fellow Dr George Hunter (Bedfordshire Hospitals NHS Foundation Trust, Bedford, UK) discusses the EXCEL trial from his perspective as a member of the PCI community, based on a recent review paper: https://www.ecrjournal.com/articles/excel-trial-interventionalists-perspective?_ga=2.187238699.2063070761.1642409370-1520007507.1640163023 from the ECR Journal. In this podcast, Dr Hunter discusses the controversy surrounding the trial and the importance of studying left main stem disease in cardiology today. If you would like to learn more about the EXCEL Trial, view our special collection here: https://www.ecrjournal.com/special-collections/445/recent Episodes are released on the last Friday of each month. If you have any questions, please email managingeditor@ecrjournal.com.
  continue reading

36 episodes

All episodes

×
 
Loading …

Welcome to Player FM!

Player FM is scanning the web for high-quality podcasts for you to enjoy right now. It's the best podcast app and works on Android, iPhone, and the web. Signup to sync subscriptions across devices.

 

Quick Reference Guide